Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-51,546
Closed -$2.4M 288
2021
Q2
$2.4M Buy
51,546
+138
+0.3% +$7.05K 0.01% 265
2021
Q1
$2.85M Buy
51,408
+713
+1% +$43.4K 0.01% 252
2020
Q4
$3.15M Hold
50,695
0.02% 230
2020
Q3
$2.97M Sell
50,695
-11,250
-18% -$833K 0.02% 221
2020
Q2
$6.91M Sell
61,945
-17,762
-22% -$1.26M 0.05% 180
2020
Q1
$5.37M Buy
79,707
+5,822
+8% +$586K 0.06% 165
2019
Q4
$10.2M Buy
73,885
+26,153
+55% +$3.39M 0.08% 154
2019
Q3
$5.01M Buy
47,732
+3,041
+7% +$304K 0.05% 183
2019
Q2
$4.75M Buy
+44,691
New +$5.89M 0.05% 185

Other funds holding OPTN

Wasatch Advisors's OPTN Position: Q3 2021 in Review

Wasatch Advisors sold out of OptiNose (OPTN) in Q3 2021, closing a stake of 51,546 shares — an estimated $2.4M sold.

Wasatch Advisors first reported a position in OPTN in Q2 2019 and held it in 9 quarters. The position peaked at $10.2M in Q4 2019. 49 funds tracked by Wall St. Rank hold OPTN as of Q3 2021.

  • Wasatch Advisors reported no remaining OptiNose position as of Q3 2021 after selling out during the quarter.
  • Wasatch Advisors sold 51,546 OptiNose shares in Q3 2021, an estimated $2.4M.
  • Wasatch Advisors first reported a position in OptiNose in Q2 2019 and held it in 9 quarters.
  • Wasatch Advisors's OptiNose position peaked at $10.2M in Q4 2019.
  • 49 funds tracked by Wall St. Rank held OptiNose as of Q3 2021.

Based on Wasatch Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.